0001235802-11-000066.txt : 20110401 0001235802-11-000066.hdr.sgml : 20110401 20110401165250 ACCESSION NUMBER: 0001235802-11-000066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110331 FILED AS OF DATE: 20110401 DATE AS OF CHANGE: 20110401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSENOW EDWARD C III CENTRAL INDEX KEY: 0001241294 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 11732201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 BARCLAY BLVD STE 280 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 BUSINESS PHONE: 8474780500 MAIL ADDRESS: STREET 1: 111 BARCLAY BLVD STE 280 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2011-03-31 0 0001023024 BIOSANTE PHARMACEUTICALS INC BPAX 0001241294 ROSENOW EDWARD C III C/O BIOSANTE PHARMACEUTICALS, INC. 111 BARCLAY BOULEVARD LINCOLNSHIRE IL 60069 1 0 0 0 Common Stock 17540 D Non-Statutory Stock Option (right to buy) 1.98 2011-03-31 4 A 0 25000 0 A 2012-03-31 2021-03-30 Common Stock 25000 25000 D /s/ Phillip B. Donenberg, attorney-in-fact 2011-03-31